BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27614089)

  • 1. The impact of serious adverse drug reactions: a population-based study of a decade of hospital admissions in New South Wales, Australia.
    Walter SR; Day RO; Gallego B; Westbrook JI
    Br J Clin Pharmacol; 2017 Feb; 83(2):416-426. PubMed ID: 27614089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of serious adverse drug reactions using diagnostic codes in the International Statistical Classification of Diseases and Related Health Problems.
    Gosselin A; Chabut C; Duhamel A; Desjardins I; Lebel D; Bussières JF
    J Popul Ther Clin Pharmacol; 2020 Jul; 27(3):e35-e48. PubMed ID: 32757540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective identification versus administrative coding of adverse drug reaction-related hospitalizations in the elderly: A comparative analysis.
    Parameswaran Nair N; Chalmers L; Peterson GM; Bereznicki BJ; Curtain CM; Bereznicki LR
    Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1281-1285. PubMed ID: 30264866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hospital readmission induced by adverse drug reaction: a pilot study in a post-emergency unit of a French university hospital].
    Chayé H; Bernard M; Tubéry M; Rousseau V; Ecoiffier M; Montastruc JL; Bagheri H
    Rev Med Interne; 2015 Jul; 36(7):450-6. PubMed ID: 25604839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in adverse drug reaction-related hospitalisations over 13 years in New South Wales, Australia.
    Zhang H; Du W; Gnjidic D; Chong S; Glasgow N
    Intern Med J; 2019 Jan; 49(1):84-93. PubMed ID: 30281186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and cost of serious adverse drug reactions in a department of general medicine.
    Moore N; Lecointre D; Noblet C; Mabille M
    Br J Clin Pharmacol; 1998 Mar; 45(3):301-8. PubMed ID: 9517375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital re-admission associated with adverse drug reactions in patients over the age of 65 years.
    Hauviller L; Eyvrard F; Garnault V; Rousseau V; Molinier L; Montastruc JL; Bagheri H
    Eur J Clin Pharmacol; 2016 May; 72(5):631-9. PubMed ID: 26884320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reactions to anticoagulants in Spain: analysis of the Spanish National Hospital Discharge Data (2010-2013).
    Carrasco-Garrido P; Hernández-Barrera V; Esteban-Hernández J; Jiménez-Trujillo I; Álvaro-Meca A; López de Andrés A; de Miguel Diez J; Rodríguez Barrios JM; Muñoz Robles JA; Jiménez-García R
    BMJ Open; 2017 Jan; 7(1):e013224. PubMed ID: 28073793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends of adverse drug reactions related-hospitalizations in Spain (2001-2006).
    Carrasco-Garrido P; de Andrés LA; Barrera VH; de Miguel GA; Jiménez-García R
    BMC Health Serv Res; 2010 Oct; 10():287. PubMed ID: 20942906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis-based and external cause-based criteria to identify adverse drug reactions in hospital ICD-coded data: application to an Australia population-based study.
    Du W; Pearson SA; Buckley NA; Day C; Banks E
    Public Health Res Pract; 2017 Apr; 27(2):. PubMed ID: 28474053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, characteristics, and reporting of adverse drug reactions in an Australian hospital: a retrospective review of hospital admissions due to adverse drug reactions.
    Li R; Curtis K; Zaidi STR; Van C; Thomson A; Castelino R
    Expert Opin Drug Saf; 2021 Oct; 20(10):1267-1274. PubMed ID: 34077311
    [No Abstract]   [Full Text] [Related]  

  • 12. Ten-year trends in hospital admissions for adverse drug reactions in England 1999-2009.
    Wu TY; Jen MH; Bottle A; Molokhia M; Aylin P; Bell D; Majeed A
    J R Soc Med; 2010 Jun; 103(6):239-50. PubMed ID: 20513902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil.
    Lobo MG; Pinheiro SM; Castro JG; Momenté VG; Pranchevicius MC
    BMC Pharmacol Toxicol; 2013 Jan; 14():5. PubMed ID: 23298396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective analysis of adverse drug reactions leading to short-term emergency hospital readmission.
    Banholzer S; Dunkelmann L; Haschke M; Derungs A; Exadaktylos A; Krähenbühl S; Liakoni E
    Swiss Med Wkly; 2021 Jan; 151():w20400. PubMed ID: 33516159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and economic impact of adverse drug reactions in hospitalized patients.
    Suh DC; Woodall BS; Shin SK; Hermes-De Santis ER
    Ann Pharmacother; 2000 Dec; 34(12):1373-9. PubMed ID: 11144691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of Adverse Drug Reaction in the Medical Wards of a Teaching Hospital: A Prospective Observational Cohort Study.
    Peter JV; Varghese GH; Alexander H; Tom NR; Swethalekshmi V; Truman C; Kumar TR; Sivakumar T
    Curr Drug Saf; 2016; 11(2):164-71. PubMed ID: 26916785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of adverse drug reactions using hospital databases-a nationwide study in Portugal.
    Miguel A; Bernardo Marques ; Freitas A; Lopes F; Azevedo L; Pereira AC
    Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):907-13. PubMed ID: 23761351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study.
    Bénard-Laribière A; Miremont-Salamé G; Pérault-Pochat MC; Noize P; Haramburu F;
    Fundam Clin Pharmacol; 2015 Feb; 29(1):106-11. PubMed ID: 24990220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
    Geer MI; Koul PA; Tanki SA; Shah MY
    J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse Drug Reactions in Children--International Surveillance and Evaluation (ADVISE): a multicentre cohort study.
    Rashed AN; Wong IC; Cranswick N; Hefele B; Tomlin S; Jackman J; Lee K; Hon KL; Ong J; Ghaleb M; Chua SS; Hui TM; Rascher W; Neubert A
    Drug Saf; 2012 Jun; 35(6):481-94. PubMed ID: 22612852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.